Dr Larisa Labzin leads a research group on viral immunity at the Institute for Molecular Bioscience (IMB), at the University of QLD, Brisbane. Dr Labzin researches the inflammatory response to viruses to better understand how acute viral infections can cause severe disease (like COVID-19). Her research aims to identify novel drug targets to boost protective immunity in susceptible populations and to treat dangerous inflammation caused by viruses. Dr Labzin received her PhD in molecular biomedicine from the University of Bonn, Germany in 2015 and was formerly an EMBO and NHMRC postdoctoral fellow at the MRC Laboratory for Molecular Biology in Cambridge, UK. Dr Labzin has received multiple awards for her research (including the Frank Fenner NHMRC Research Excellence Award in 2016 and a QLD Tall Poppy Award in 2022) and secured over $1.9M in research funding. During the COVID-19 pandemic Dr Labzin has been heavily involved in public outreach, giving both community and business lectures to explain the fundamental science of COVID-19, and over 60 media interviews (national and international, television, radio, and print).